Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

OBJECTIVES: To determine in a retrospective cohort whether patients with psoriatic arthritis (PsA) who would not have fulfilled the inclusion criteria for randomised controlled trials (RCTs) for the TNF inhibitor (TNFi) chosen for their treatment (excl) have similar benefits and drug survival as tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Palsson, Olafur, Love, Thorvardur Jon, Gunnarsdottir, Anna Ingibjorg, Gunnarsson, Petur Sigurdur, Runarsdottir, Eydis Erla, Krogh, Niels Steen, Gudbjornsson, Bjorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667974/
https://www.ncbi.nlm.nih.gov/pubmed/31413869
http://dx.doi.org/10.1136/rmdopen-2019-000984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667974/
https://www.ncbi.nlm.nih.gov/pubmed/31413869
http://dx.doi.org/10.1136/rmdopen-2019-000984

Ejemplares similares